SEER Inquiry System - Question 20150018 Details

System Guide

Back to Search Results

SEER Inquiry System - Report

Produced: 04/04/2026 12:56 AM

Question 20150018

Export CSV Export PDF Print

Add to Report

Inquiry Details

References:

#1: 2015 SEER Manual, 143

#2: SEER*Rx

Question:

First course of treatment--Immunotherapy: Should Rituxan be coded to immunotherapy? See discussion.

Discussion:

Is the instruction under #4.b. on page 114 of the 2014 SEER Program Coding and Staging Manual incorrect? It says to code Rituxan as chemotherapy.

Answer:

Rituxan changed categories from chemotherapy to a biologic therapy/Immunotherapy agent effective with cases diagnosed January 1, 2013. See page 150 or page 164 in the 2015 SEER manual. The instruction in the 2014 SEER manual was incorrect regarding Rituxan.

Cancer Site Category:

N/A

Data Item Category:

First course treatment, Immunotherapy

Other Category:

N/A

Year:

2015